Vivozon Pharmaceutical Co., Ltd. (KOSDAQ: 082800)

Vivozon Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	398,986	144,635	149,085	186,048	296,774	249,937
Market Cap Growth	26.74%	-2.99%	-19.87%	-37.31%	18.74%	146.51%
Enterprise Value	426,897	174,909	188,576	192,882	339,521	372,366
Last Close Price	8080.00	3000.00	3185.00	5475.00	10550.00	10475.00
PS Ratio	4.39	2.03	2.89	3.23	6.81	5.56
PB Ratio	3.65	1.39	1.44	2.15	2.66	2.29
P/TBV Ratio	1.86	1.45	1.52	2.43	4.76	2.30
P/FCF Ratio	-	-	-	-	79.02	-
P/OCF Ratio	25.94	48.35	-	-	64.17	-
EV/Sales Ratio	4.89	2.45	3.66	3.35	7.79	8.28
EV/EBITDA Ratio	54.56	22.04	-	-	-	-
EV/EBIT Ratio	99.65	37.14	-	-	-	-
EV/FCF Ratio	-723.67	-	-	-	90.41	-
Debt / Equity Ratio	0.38	0.40	0.58	0.97	0.97	0.38
Debt / EBITDA Ratio	5.08	5.24	-	-	-	-
Debt / FCF Ratio	-	-	-	-	28.87	-
Asset Turnover	0.49	0.40	0.27	0.26	0.21	0.34
Inventory Turnover	2.66	3.31	2.21	2.62	4.67	7.96
Quick Ratio	0.18	0.48	0.45	0.87	0.91	1.37
Current Ratio	0.64	0.70	0.60	1.08	1.06	1.46
Return on Equity (ROE)	-2.75%	-2.13%	-28.26%	-71.70%	-39.98%	-25.52%
Return on Assets (ROA)	1.51%	1.63%	-3.21%	-5.54%	-2.43%	-1.31%
Return on Capital (ROIC)	1.81%	1.90%	-3.67%	-6.28%	-2.71%	-1.44%
Earnings Yield	-0.71%	-2.32%	-26.77%	-37.33%	-14.74%	-11.20%
FCF Yield	-0.15%	-1.06%	-6.58%	-14.84%	1.27%	-1.64%
Buyback Yield / Dilution	0.49%	-9.69%	-33.41%	-24.52%	-24.63%	-65.66%
Total Shareholder Return	0.49%	-9.69%	-33.41%	-24.52%	-24.63%	-65.66%

Source: S&P Capital IQ. Standard template. Financial Sources.